Chiedozie Anoka

Global Development Scientist Director, Imunno-oncology at AstraZeneca

Chiedozie Anoka, PharmD, is a Global Development Scientist Director specializing in Immuno-oncology at AstraZeneca since July 2014, where responsibilities include the development and design of studies to assess the scientific and clinical viability of oncology products, as well as involvement in protocol design and compliance with GCP, ICH, and quality standards. Prior to this role, Chiedozie served as a Senior Pharmacovigilance Scientist focusing on patient safety. Chiedozie gained early experience as a Pharmacy Intern at Yale New Haven Health System and completed an internship at VA Connecticut Healthcare System. Chiedozie holds a Doctor of Pharmacy degree from the University of Saint Joseph (2011-2014) and a Bachelor's degree in Biotechnology from Drexel University (2005-2008).

Links

Previous companies

Yale New Haven Health logo

Timeline

  • Global Development Scientist Director, Imunno-oncology

    January, 2020 - present

  • Senior Pharmcovigilance Scientist

    July, 2014